Combination of telmisartan plus amlodipine in the treatment of hypertension: Review of results

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 11, 2010, Pages 1509-1517

  Oigman, Wille ^a   Neves, Mario Fritsch ^a   Gismondi, Ronaldo Aoc ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

amlodipine; angiotensin receptor blocker; calcium channel blocker; hypertension; telmisartan

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYDROCHLOROTHIAZIDE; LISINOPRIL; PERINDOPRIL; PLACEBO; RAMIPRIL; TELMISARTAN; THIAZIDE DIURETIC AGENT;

ANGIONEUROTIC EDEMA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COUGHING; DISEASE CONTROL; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG WITHDRAWAL; FACTORIAL DESIGN; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; POST HOC ANALYSIS; REVIEW; SYNCOPE; SYSTOLIC HYPERTENSION; TREATMENT RESPONSE;

AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; TREATMENT OUTCOME;

EID: 78649390591     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.143     Document Type: Review

References (32)

1. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513-1518 (2008).
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of Hypertension 1988-2008. JAMA 303, 2043-2050 (2010).
3. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplifed approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 53, 646-653 (2009).
4. Domino FJ. Improving adherence to treatment for hypertension. Am. Fam. Physician 71, 2089-2090 (2005).
5. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 23, 1296-1310 (2001).
6. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-ana lysis. Am. J. Med. 120, 713-719 (2007).
7. Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 28, 1462-1536 (2007).
8. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am. J. Cardiol. 95, 29-35 (2005).
9. Smith DH. Fixed-dose combination antihypertensives and reduction in target organ damage: are they all the same? Am. J. Cardiovasc. Drugs 7, 413-422 (2007).
10. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252 (2003).
11. Williams B, Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS I V. J. Hum. Hypertens. 18, 139-185 (2004)
12. V Brazilian Guidelines in arterial hypertension. Arq. Bras. Cardiol. 89, e24-e79 (2007).
13. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288, 2981-2997 (2002).
14. Dahlof B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendrofumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366, 895-906 (2005).
15. Poulter NR, Wedel H, Dahlof B et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 366, 907-913 (2005).
16. Jamerson K, Weber MA, Bakris GL et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 359, 2417-2428 (2008).
17. Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 358, 1547-1559 (2008).
18. Sharpe M, Jarvis B, Goa KL. Telmisartan: a review of its use in hypertension. Drugs 61, 1501-1529 (2001). (Pubitemid 32783749)
19. Sharma A, Bagchi A, Kinagi SB, Sharma YK, Baliga VP, Bollmall C. Results of a comparative, Phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the effcacy and tolerability of a fxed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. Clin. Ther. 29, 2667-2676 (2007).
20. Fogari R, Derosa G, Zoppi A. Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria. Am. J. Hypertens. 20, 417-422 (2007).
21. Benson SC, Pershadsingh HA, Ho CI et al. Identifcation of telmisartan as a unique angiotensin II receptor antagonist with selective PPARg-modulating activity. Hypertension 43, 993-1002 (2004).
22. Stangier J, Su CA. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers. J. Clin. Pharmacol. 40, 1347-1354 (2000).
23. Neldam S, Lang M; on behalf of the TEAMSTA-5 Investigators. Fixed-dose combination therapy with telmisartan and amlodipine 5mg in non-responders to amlodipine 5mg provides superior blood pressure reductions to, and is associated with less peripheral oedema than amlodipine 10mg. Presented at: 19th Scientifc Meeting of the European Society of Hypertension (ESH). Milan, Italy, 12-16 June 2009.
24. Neldam S, Edwards C; on behalf of the TEAMSTA-10 Investigators. Switch to a fxed-dose combination therapy with telmisartan and amlodipine provides signifcant blood pressure reduction and control in patients not adequately controlled with amlodipine 10 mg. Presented at: 19th Scientifc Meeting of the European Society of Hypertension (ESH). Milan, Italy, 12-16 June 2009.
25. Littlejohn TW 3rd, Majul CR, Olvera R et al. Results of treatment with telmisartan-amlodipine in hypertensive patients. J. Clin. Hypertens. (Greenwich) 11, 207-213 (2009).
26. White WB, Majul CR, Oigman W et al. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. Blood Press. Monit. 15(4), 205-212 (2010).
27. Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Kobe H. Telmisartan in combination with amlodipine provides an effective treatment option for patients with diabetes: sub-ana lysis from a factorial design study. Presented at: 24th Annual Scientifc Meeting American Society of Hypertension. San Francisco, CA, USA, 6-9 May 2009.
28. Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Kobe H. Effcacy of telmisartan in combination with amlodipine in obese hypertensive patients: sub-ana lysis from a factorial design study. Presented at: 24th Annual Scientifc Meeting American Society of Hypertension. San Francisco, CA, USA, 6-9 May 2009.
29. Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Kobe H. Combination of telmisartan with amlodipine provides an effective treatment option for patients with elevated systolic hypertension: sub-ana lysis from a factorial design study. Presented at: 24th Annual Scientifc Meeting American Society of Hypertension. San Francisco, CA, USA, 6-9 May 2009.
30. Littlejohn T W, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial study. Postgrad. Med. 121, 14-19 (2009).
31. Neutel JM, Mancia G, Black HR, Dahlof B, Defeo H, Ley L, Vinisko R. Telmisartan 80 mg/amlodipine 10 mg provides superior blood pressure reductions in patients with severe hypertension: TEAMSTA Severe HTN Study. Presented at: 25th Annual Scientifc Meeting of the American Society of Hypertension. New York, NY, USA, 1-4 May 2010.
32. Faruqui AA. Evaluation of safety and effcacy of telmisartan-amlodipine combination in treating hypertension. J. Indian Med. Assoc. 106, 612-614 (2008).